Introduction: The aim was to investigate whether the stem cell marker LGR6 has prognostic value in colon cancer, alone or in combination with the prognostic biomarkers CEA and CXCL16.
Methods: LGR6 mRNA levels were determined in 370 half lymph nodes of 121 colon cancer patients. Ability to predict relapse after curative surgery was estimated by Kaplan-Meier survival model and Cox regression analyses.
Results: Patients with high LGR6 levels [LGR6(+)] had a decreased mean survival time of 11 months at 5-year follow-up and 47 months at 12-year follow-up, respectively, with hazard ratios of 3.2 and 2.8. LGR6 mRNA analysis added prognostic value to CEA and CXCL16 mRNA analysis. In the poor prognosis groups CEA(+) and CXCL16(+), further division was achieved by LGR6 analysis. LGR6(+) patients had a very poor prognosis. LGR6 also identified a small number of CEA(-), TNM stage I patients who relapsed suggesting stem cell origin of these tumors. LGR6 and LGR5 levels correlated strongly in lymph nodes of stage I and IV patients but not in stage II patients, suggesting that these stem cell markers are differentially regulated.
Conclusion: This study highlights LGR6 as a useful prognostic biomarker independently and in combination with CEA, CXCL16 or LGR5 identifying different risk groups.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074358 | PMC |
| http://dx.doi.org/10.3389/fonc.2024.1393075 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis.
Comput Biol Med
August 2024
Gynecology Department, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China; Key Laboratory of Fertility Preservation & Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, 750000, China. Electronic address:
Article Synopsis
- * Researchers utilized data from TCGA and GEO databases and applied LASSO Cox regression to develop a prognostic model based on 17 GPCR-related genes (GPCRRGs), with notable findings in gene expression levels that aid in accurate diagnosis.
- * The model effectively distinguished between high-risk and low-risk ovarian cancer patients, indicating potential for better prognosis prediction and insight into immune system behavior within the tumor environment.
LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients.
Front Oncol
April 2024
Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Introduction: The aim was to investigate whether the stem cell marker LGR6 has prognostic value in colon cancer, alone or in combination with the prognostic biomarkers CEA and CXCL16.
Methods: LGR6 mRNA levels were determined in 370 half lymph nodes of 121 colon cancer patients. Ability to predict relapse after curative surgery was estimated by Kaplan-Meier survival model and Cox regression analyses.
Construction of an immune-related gene signature for overall survival prediction and immune infiltration in gastric cancer.
World J Gastrointest Oncol
March 2024
Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Background: Treatment options for patients with gastric cancer (GC) continue to improve, but the overall prognosis is poor. The use of PD-1 inhibitors has also brought benefits to patients with advanced GC and has gradually become the new standard treatment option at present, and there is an urgent need to identify valuable biomarkers to classify patients with different characteristics into subgroups.
Aim: To determined the effects of differentially expressed immune-related genes (DEIRGs) on the development, prognosis, tumor microenvironment (TME), and treatment response among GC patients with the expectation of providing new biomarkers for personalized treatment of GC populations.
Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer.
Aging (Albany NY)
April 2023
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, Beijing 100730, People’s Republic of China.
Background: Gastric cancer (GC) is a malignant tumor with high prevalence and fatality. Cuproptosis is a recently identified copper-dependent programmed cell death mechanism. Multiple studies have demonstrated the profound impact of the immune microenvironment on tumor development.
View Article and Find Full Text PDFHigh expression of LGR6 is a poor prognostic factor in esophageal carcinoma.
Pathol Res Pract
February 2023
First Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Article Synopsis
- LGR6 is a receptor linked to cancer progression, specifically studied in esophageal squamous cell carcinoma (ESCC) using RNAscope, a precise RNA detection method.
- In a study involving 41 ESCC cases, 37 showed LGR6 expression, with higher levels in aggressive tumors and those treated with neoadjuvant chemotherapy.
- High levels of LGR6 expression correlate with poorer patient prognosis, suggesting its potential as a prognostic indicator and a target for future therapies in ESCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!